Trevi Therapeutics, Inc. TRVI Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Trevi Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The official record: Trevi Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Trevi Therapeutics, Inc.'s investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Trevi Therapeutics, Inc.'s investing cash flow?
- Trevi Therapeutics, Inc. (TRVI) reported investing cash flow of $16.97M in Q1 2026.
- How has Trevi Therapeutics, Inc.'s investing cash flow changed year-over-year?
- Trevi Therapeutics, Inc.'s investing cash flow increased by 270.5% year-over-year, from -$9.95M to $16.97M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.